Nexalin Ownership | Who Owns Nexalin?
Nexalin Ownership Summary
Nexalin is owned by 2.13% institutional investors, 13.78% insiders, and 84.09% retail investors. Peak6 is the largest institutional shareholder, holding 2.35% of NXL shares.
NXL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nexalin | 2.13% | 13.78% | 84.09% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Medical Device Stocks | 37.83% | 10.48% | 51.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Peak6 | 384.46K | 2.35% | $133.91K |
| Vanguard group | 177.92K | 1.00% | $99.28K |
| Geode capital management | 150.27K | 0.84% | $83.85K |
| Morgan stanley | 59.80K | 0.80% | $101.07K |
| Cvi | 55.46K | 0.75% | $93.73K |
| Renaissance | 122.10K | 0.69% | $68.13K |
| Vanguard fiduciary trust | 51.39K | 0.31% | $17.88K |
| State street | 32.30K | 0.21% | $29.63K |
| Northern trust | 24.10K | 0.15% | $22.11K |
| Kovack advisors | 23.32K | 0.14% | $8.20K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cvi | 55.46K | 0.08% | $93.73K |
| Xtx topco | 11.91K | 0.00% | $10.92K |
| Kovack advisors | 23.32K | 0.00% | $8.20K |
| Peak6 | 384.46K | 0.00% | $133.91K |
| Atria wealth solutions | 10.35K | 0.00% | $10.22K |
| Renaissance | 122.10K | 0.00% | $68.13K |
| Ifp advisors | - | - | - |
| Tower research capital llc (trc) | 1.43K | - | $1.31K |
| Rockefeller capital management | 1.50K | - | $1.38K |
| Myda advisors | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 122.10K | 0.00% | 66.40K |
| Morgan stanley | 59.80K | - | 59.80K |
| Cvi | 55.46K | 0.08% | 55.46K |
| Vanguard fiduciary trust | 51.39K | - | 51.39K |
| Geode capital management | 150.27K | - | 28.45K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Myda advisors | - | - | -150.00K |
| Peak6 | 384.46K | 0.00% | -92.05K |
| Susquehanna group, llp | - | - | -42.38K |
| Jane street group | 10.51K | - | -24.51K |
| Virtu financial | - | - | -23.45K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Morgan stanley | 59.80K | - | 59.80K | $101.07K |
| Cvi | 55.46K | 0.08% | 55.46K | $93.73K |
| Vanguard fiduciary trust | 51.39K | - | 51.39K | $17.88K |
| Rockefeller capital management | 1.50K | - | 1.50K | $1.38K |
| Wells fargo & company/mn | 1.00K | - | 1.00K | $348.00 |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -88.00 |
| Spire wealth management | -300.00 |
| Stone house investment management | -357.00 |
| Princeton global asset management | -1.00K |
| Ifp advisors | -2.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | -70.00% | 378,903 | -45.53% | 2 | 10.87% | 5 | -37.50% | - | -100.00% |
| Sep 30, 2025 | 4 | -78.95% | 187,720 | -85.26% | 1 | 1.82% | 2 | -81.82% | - | - |
| Jun 30, 2025 | 21 | 23.53% | 1,314,236 | 230.95% | 8 | 93.89% | 13 | 85.71% | - | -100.00% |
| Mar 31, 2025 | 17 | -5.56% | 397,116 | 6.95% | 2 | 25.47% | 8 | -50.00% | 3 | 200.00% |
| Dec 31, 2024 | 17 | 21.43% | 339,026 | -20.83% | 3 | 20.05% | 15 | 66.67% | 1 | -66.67% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 10, 2025 | Elson Marilyn | - | Sell | $96.07K |
| Mar 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy | $13.20K |
| Feb 04, 2025 | Owens David | Chief Medical Officer | Buy | $3.10K |
| Feb 04, 2025 | Owens David | Chief Medical Officer | Buy | $2.98K |
| Nov 02, 2024 | Kazden Alan | - | Buy | $246.75K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2025 Q3 | - | - |
| 2025 Q1 | 6 | - |
| 2024 Q4 | 2 | - |
| 2024 Q3 | 1 | - |
NXL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools